Navigation Links
Micromet's Blinatumomab Achieves Primary Endpoint in Phase 2 Study with Acute Lymphoblastic Leukemia Patients
Date:6/8/2009

of treatment with bcr-abl inhibitors, and patients with t(4;11) translocations. Side effects were observed primarily in the first 24 to 48 hours with transient pyrexia and lympho-/leukopenia being the most frequent adverse events.

"Blinatumomab is one of the most active agents the GMALL has tested in the adult ALL consolidation setting," said Dr. Ralf Bargou, principal investigator of the trial. "We are excited about the significant activity of blinatumomab in ALL and the favorable safety profile observed in this study. These results are particularly important for these patients who are in a disease stage with extremely poor prognosis and for which we lack treatment options except for patients eligible for allogenic stem cell transplantations."

"The ALL interim data showing an MRD response rate above 80% significantly exceeds the rate which was considered to be clinically meaningful and was set as the hurdle for the achievement of the primary end point," said Micromet's Senior Vice President and Chief Medical Officer, Carsten Reinhardt, M.D. "We are now looking forward to discussing a pivotal ALL program with the regulatory authorities later this year."

    (1) Topp, M.S. et al (2009). Blinatumomab (anti-CD19 BiTE(R)) for targeted
        therapy of minimal residual disease (MRD) in patients with B precursor
        acute lymphoblastic leukemia (ALL): Update of an ongoing Phase II
        study. 14th Congress of the EHA 2009, abstract no. 482


Webcast/Conference Call

Micromet will host a webcast/conference call this morning from 9:00 am to 11:00 am U.S. Eastern time to discuss the blinatumomab data presented at the 14th Congress of the European Hematology Association. The webcast will be available on the company's website at www.micromet-inc.com. To participate in the conference call, dial 866
'/>"/>

SOURCE Micromet, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Micromets BiTE Antibody Blinatumomab (MT103/MEDI-538) Demonstrates Durable Responses in Patients with Relapsed Non-Hodgkins Lymphoma
2. Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia
3. Clinical Data Published in Science Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab
4. Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE
5. Micromet Presents Update on Blinatumomabs Response Rate and Duration in a Phase 1 Study in Non-Hodgkins Lymphoma Patients
6. Large Blinded Clinical Study Achieves High Accuracy for the Diagnosis of Melanoma Using In Vivo Confocal Microscopy
7. Avastin Achieves Impressive Rate of Curative Surgery in Patients with Advanced Colorectal Cancer
8. Cethromycin Achieves All Endpoints in Second Pivotal Phase III Trial for Treatment of Pneumonia
9. PLC Systems Achieves Successful Early Conclusion of RenalGuard(TM) Pilot Safety Trial
10. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
11. Surface Logix Achieves Objectives With SLx-2101 in Phase 2a Clinical Trial in Hypertension
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... 2015 Research and Markets ( ... "Eurpoean Automatic External Defibrillators (AED) Market by ... Market, Hospitals, Alternate Care Market, Home) - Forecast ... The European automated external defibrillator (AED) market ... 10.9% from 2014 to 2019 ...
(Date:3/31/2015)... 2015 The Medical Letter is pleased ... American Medical Group Association,s "High Performing Health" News ... "High Performing Health" production is an online news ... healthcare system in delivering better care at lower ... other leading organizations in the healthcare sector in ...
(Date:3/31/2015)... 31, 2015 Accelerated orthodontic treatment will ... of Orthodontics 2015 Annual Session, May 15-19, as ... lectures on AcceleDent ® . Manufactured by OrthoAccel ... orthodontics, AcceleDent is a FDA-cleared, Class II medical ... much as 50 percent with just 20 minutes ...
Breaking Medicine Technology:Eurpoean Automatic External Defibrillators (Semi-Automated, Fully-Automated) Market 2015-2019 - Pre-Hospitals, Public Access Market, Hospitals, Alternate Care Market, Home Analysis 2Eurpoean Automatic External Defibrillators (Semi-Automated, Fully-Automated) Market 2015-2019 - Pre-Hospitals, Public Access Market, Hospitals, Alternate Care Market, Home Analysis 3AMGA's High Performing Health News Program Features The Medical Letter 2Leading Orthodontists to Advance Accelerated Treatment at AAO 2015 2Leading Orthodontists to Advance Accelerated Treatment at AAO 2015 3
... 2011 ConvaTec Healthcare, a world-leading developer, manufacturer and ... care, today announced that, following a review of current ... refinancing of its senior secured term loans originally entered ... ConvaTecConvaTec is a leading developer and marketer of innovative ...
... March 17, 2011 Giant Eagle®, the region,s leading ... Association,s (ADA) prestigious Chairman,s Citation Award. Giant ... which recognizes the outstanding accomplishments of individuals, corporations, institutions ... and have had a positive impact in advancing the ...
Cached Medicine Technology:ConvaTec Healthcare Postpones Plans To Refinance Secured Term Loans 2ConvaTec Healthcare Postpones Plans To Refinance Secured Term Loans 3Giant Eagle® Receives American Diabetes Association Chairman's Citation Award 2Giant Eagle® Receives American Diabetes Association Chairman's Citation Award 3
(Date:3/31/2015)... Purchase, NY (PRWEB) March 31, 2015 ... to announce the presentation of new clinical study ... bonded arginine silicate (ASI), titled, “Arginine Silicate Supplementation ... and Increases Markers of Vasodilation and Cardiovascular Health ... to scientists and other professionals at the acclaimed ...
(Date:3/31/2015)... Colo. (PRWEB) March 31, 2015 As ... Global Energy Balance Network (GEBN) is poised ... to improve public health. GEBN is a network ... Caribbean, Europe, Africa, Asia and Oceania who have banded ... energy utilization by the body (energy balance) and apply ...
(Date:3/31/2015)... Tickets are now on sale for Showtime ... 1973. The 2015 Spring production, Fairy Tales on Ice ... April 24 in partnership with the Alzheimer's Association there ... to the Pat Bowlen family, long-time partners and sponsors ... event proceeds will go to the Alzheimer's Association of ...
(Date:3/31/2015)... 31, 2015 QMedET Solutions, LLC, ... bringing the industry’s most advanced speech recognition technology ... Physicians can now experience the full benefits of ... offering value-added support services that ensure successful integration ... “QMedET is proud to provide Dragon Medical Practice ...
(Date:3/31/2015)... The status of more than 1,000 Mirena ... Management Conference scheduled to be held in the U.S. ... 21st. According to court documents, the jurisdiction is currently ... lawsuits filed on behalf of women who allegedly suffered ... to the birth control device. (In re: Mirena IUD ...
Breaking Medicine News(10 mins):Health News:Nutrition 21, LLC Announces the Presentation of Proteomic Results of a Nitrosigine® Clinical Study at the Renowned Experimental Biology 2015 Annual Meeting 2Health News:Nutrition 21, LLC Announces the Presentation of Proteomic Results of a Nitrosigine® Clinical Study at the Renowned Experimental Biology 2015 Annual Meeting 3Health News:Nutrition 21, LLC Announces the Presentation of Proteomic Results of a Nitrosigine® Clinical Study at the Renowned Experimental Biology 2015 Annual Meeting 4Health News:Nutrition 21, LLC Announces the Presentation of Proteomic Results of a Nitrosigine® Clinical Study at the Renowned Experimental Biology 2015 Annual Meeting 5Health News:Nutrition 21, LLC Announces the Presentation of Proteomic Results of a Nitrosigine® Clinical Study at the Renowned Experimental Biology 2015 Annual Meeting 6Health News:Global Energy Balance Network Experts from Six Continents Join Forces to Reduce Obesity, Including the University of Colorado Anschutz Health and Wellness Center's James O. Hill, PhD 2Health News:Global Energy Balance Network Experts from Six Continents Join Forces to Reduce Obesity, Including the University of Colorado Anschutz Health and Wellness Center's James O. Hill, PhD 3Health News:QMedET Solutions Announces Addition of Dragon® Medical Practice Edition 2 to its Roster of Products 2Health News:Mirena IUD Lawsuits Move Forward as Federal Court Readies to Convene Next Case Management Conference 2Health News:Mirena IUD Lawsuits Move Forward as Federal Court Readies to Convene Next Case Management Conference 3
... SENSE OF URGENCY ABOUT HIV/AIDS EPIDEMIC ABROADMENLO PARK, Calif., ... (39%) or increasing (26%) U.S. government funding to improve ... (23%) say the government is spending too much on ... of the American people,s attitudes towards U.S. global health ...
... 7 Hospira, Inc. (NYSE: HSP ), a ... the company will present at the Bank of America and ... 2009, in New York City.The presentation is scheduled to begin ... It will be available to all interested parties through ...
... (Nasdaq: ALSE ; Alseres) announced today that effective ... the NASDAQ Capital Market will be suspended. Effective at ... quotation on the Pink Sheets under the ticker ALSE. ... on the OTC bulletin board.(Logo: http://www.newscom.com/cgi-bin/prnh/20080813/NEW056LOGO ...
... Pharma GmbH received an Orphan Drug Designation (ODD) by ... the EMEA for inhaled PARI Tobramycin 100 delivered via ... the second ODD designation that PARI Pharma has received ... first ODD was granted for PARI,s inhaled cyclosporine delivered ...
... Currently, patients taking anticoagulants to prevent stroke and blood ... order to perform colonoscopy with removal of polyps., However, ... of stroke and blood clots. A group led by ... California reported their experience removing small colon polyps without ...
... 7 Apex Bioventures Acquisition Corporation (NYSE Amex: ... stockholders will be held at 10:00 a.m. local time on ... Cohn Ferris Glovsky & Popeo, P.C., located at 666 Third ... Apex,s stockholders will be asked to consider and vote on ...
Cached Medicine News:Health News:Americans Say Maintain or Increase Funding for Global Health and Development, But Take Care of Problems at Home First in the Recession 2Health News:Americans Say Maintain or Increase Funding for Global Health and Development, But Take Care of Problems at Home First in the Recession 3Health News:Americans Say Maintain or Increase Funding for Global Health and Development, But Take Care of Problems at Home First in the Recession 4Health News:Americans Say Maintain or Increase Funding for Global Health and Development, But Take Care of Problems at Home First in the Recession 5Health News:Americans Say Maintain or Increase Funding for Global Health and Development, But Take Care of Problems at Home First in the Recession 6Health News:Alseres Shares Begin Trading on the Pink Sheets OTC Market 2Health News:Alseres Shares Begin Trading on the Pink Sheets OTC Market 3Health News:Alseres Shares Begin Trading on the Pink Sheets OTC Market 4Health News:PARI Pharma Receives 2nd ODD From EMEA; Moves Inhaled Tobramycin - eFlow Technology Program Forward 2Health News:PARI Pharma Receives 2nd ODD From EMEA; Moves Inhaled Tobramycin - eFlow Technology Program Forward 3Health News:PARI Pharma Receives 2nd ODD From EMEA; Moves Inhaled Tobramycin - eFlow Technology Program Forward 4Health News:Apex Bioventures Acquisition Corp. Sets Date for Special Meeting of Stockholders to Approve Dissolution 2
... Flexible CystoNephroscope is used for percutaneous and ... practice. The large 6.4 Fr (2.1 mm) ... operating instruments for therapeutic applications. The flexible ... covered tip provide fast, less traumatic access ...
Inquire...
Used to obtain tissue biopsy under direct vision. Cup Biopsy Forceps are designed for use through rigid or flexible endoscopes. Supplied sterile in peel-open packages. Intended for one-time use....
Electric Reciprocating Saw, with hand throttle. Can also be purchased without hand throttle (#1915) for use with foot pedal. (#6401-000)...
Medicine Products: